Tim Ermak
Co-founder & CTO - Silica Corpora
With 12+ years of experience in applying artificial intelligence, machine learning to solve complex problems in biopharma, Tim Ermak is a co-founder and CTO of Silica Corpora, a startup that leverages generative AI to design antibodies de novo for more effective therapeutics. He gained a PhD-equivalent experience in bioinformatics and holds an MBA in Life Science Management degree, which equip him with a unique combination of technical and business skills for leading a cutting-edge venture in the life science sector.
Tim's mission is to bring innovation and excellence to the field of antibody engineering and design, and to create value and impact for patients and society with Silica Corpora.
